Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,367 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Elimination of human T cell leukemia virus type-1-infected cells by neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies against human t cell leukemia virus type-1 envelope gp46.
Tanaka Y, Takahashi Y, Tanaka R, Kodama A, Fujii H, Hasegawa A, Kannagi M, Ansari AA, Saito M. Tanaka Y, et al. Among authors: tanaka r. AIDS Res Hum Retroviruses. 2014 Jun;30(6):542-52. doi: 10.1089/aid.2013.0214. Epub 2014 Mar 10. AIDS Res Hum Retroviruses. 2014. PMID: 24524420
A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity.
Ichiyama K, Yokoyama-Kumakura S, Tanaka Y, Tanaka R, Hirose K, Bannai K, Edamatsu T, Yanaka M, Niitani Y, Miyano-Kurosaki N, Takaku H, Koyanagi Y, Yamamoto N. Ichiyama K, et al. Among authors: tanaka r, tanaka y. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4185-90. doi: 10.1073/pnas.0630420100. Epub 2003 Mar 17. Proc Natl Acad Sci U S A. 2003. PMID: 12642669 Free PMC article.
Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.
Yoshida A, Tanaka R, Murakami T, Takahashi Y, Koyanagi Y, Nakamura M, Ito M, Yamamoto N, Tanaka Y. Yoshida A, et al. Among authors: tanaka r, tanaka y. J Virol. 2003 Aug;77(16):8719-28. doi: 10.1128/jvi.77.16.8719-8728.2003. J Virol. 2003. PMID: 12885891 Free PMC article.
Repression of tax expression is associated both with resistance of human T-cell leukemia virus type 1-infected T cells to killing by tax-specific cytotoxic T lymphocytes and with impaired tumorigenicity in a rat model.
Nomura M, Ohashi T, Nishikawa K, Nishitsuji H, Kurihara K, Hasegawa A, Furuta RA, Fujisawa J, Tanaka Y, Hanabuchi S, Harashima N, Masuda T, Kannagi M. Nomura M, et al. Among authors: tanaka y. J Virol. 2004 Apr;78(8):3827-36. doi: 10.1128/jvi.78.8.3827-3836.2004. J Virol. 2004. PMID: 15047798 Free PMC article.
Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
Mori N, Matsuda T, Tadano M, Kinjo T, Yamada Y, Tsukasaki K, Ikeda S, Yamasaki Y, Tanaka Y, Ohta T, Iwamasa T, Tomonaga M, Yamamoto N. Mori N, et al. Among authors: tanaka y. J Virol. 2004 May;78(9):4582-90. doi: 10.1128/jvi.78.9.4582-4590.2004. J Virol. 2004. Retraction in: J Virol. 2011 Feb;85(3):1415. doi: 10.1128/JVI.02069-10 PMID: 15078940 Free PMC article. Retracted.
Potential immunogenicity of adult T cell leukemia cells in vivo.
Kurihara K, Harashima N, Hanabuchi S, Masuda M, Utsunomiya A, Tanosaki R, Tomonaga M, Ohashi T, Hasegawa A, Masuda T, Okamura J, Tanaka Y, Kannagi M. Kurihara K, et al. Among authors: tanaka y. Int J Cancer. 2005 Mar 20;114(2):257-67. doi: 10.1002/ijc.20737. Int J Cancer. 2005. PMID: 15551352
15,367 results
You have reached the last available page of results. Please see the User Guide for more information.